In Latin America and the Caribbean, the death toll from the CCP virus has now surpassed one million.
According to the Pan American Health Organization (PAHO), nearly 89 percent of deaths in Latin America and the Caribbean occurred in Brazil (44.3 percent), Mexico (22.1 percent), Colombia (8.3 percent), Argentina (7.3 percent), and Peru as of May 21. (6.7 percent). Three percent of the deaths occurred in Central America, and one percent occurred in the Caribbean.
Brazil had more than 462,000 deaths attributed to the pandemic as of May 31, the world’s second-highest reported death toll after the United States. Mexico ranks second in the region with over 223,000 deaths, followed by Colombia with over 88,000 deaths.
Currently, PAHO has delivered over 12 million doses of vaccines obtained through the World Health Organization’s COVID-19 vaccines global access initiative to Latin America and the Caribbean, with an additional 770,000 doses on their way.
According to data from the Pan American Health Organization, several Latin American countries, including Chile, El Salvador, Brazil, and Uruguay, rely almost entirely on vaccines manufactured in China.
The Chinese communist regime’s Xinhua News Agency reported on May 20 that Chinese vaccines Sinovac, Sinopharm, and CanSino are being widely distributed in Latin American countries including Brazil, Chile, Mexico, Argentina, and Peru.
According to the report, as of May 14, 26 Latin American and Caribbean countries had received more than 84 million doses of COVID-19 vaccines, according to the most recent PAHO statistics. Nearly 55 million doses, or roughly 65 percent, were Chinese vaccines.
According to NBC, China has recently shipped more than 165 million doses of Chinese vaccines to Latin America and the Caribbean.
According to experts cited in the report, the Chinese Communist Party (CCP) is using vaccines to advance its agenda in Latin America. Officials in Latin America have also stated that the CCP has asked Latin America to cut ties with Taiwan in exchange for the vaccine.
Many South and Central American and Middle Eastern countries that have embraced communist China’s “vaccine diplomacy,” including Brazil, Chile, Pakistan, and Turkey, have seen an increase in confirmed viral infections and severe side effects among vaccine recipients following widespread administration of the Sinovac vaccine.
Gao Fu, director of China’s Center for Disease Control and Prevention, admitted on April 10 at a Chinese national conference on vaccines and health that China’s vaccines don’t provide much protection and that the effectiveness could be improved by alternating between different types of vaccines.
In January, the Instituto Butantan, a leading Brazilian vaccine producer, reduced the effectiveness rate of the Sinovac vaccine from 77.96 percent to 50.38 percent, and in March, three phases of clinical trials in Peru of the Sinopharm vaccine revealed that the vaccine by Beijing Bio, a subsidiary of Sinopharm, was only 11.5 percent effective; Wuhan Bio’s vaccine was 33 percent effective, far better than the vaccine by Beijing Bio, which was only 11.5 percent effective.